MacKay Douglas Jesse 4
4 · CV Sciences, Inc. · Filed Mar 11, 2021
Insider Transaction Report
Form 4
MacKay Douglas Jesse
Sr VP Scientific/Regulatory
Transactions
- Award
Employee Stock Option (right to buy)
2021-03-09+400,000→ 400,000 totalExercise: $0.59Exp: 2031-03-08→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The option is durational-based. No option shares are vested on the date of grant. Twenty-five percent (25%) of the option shares vest and become exercisable on each of the following dates: September 1, 2021, March 1, 2022, September 1, 2022, and March 1, 2023, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service.